In both LMNA H222P mouse models and patients, the activation of the AKT1/MTOR pathway, as well as the phosphorylation of MAPK3/1 (ERK1/2), is increased prior to the manifestation of clinical features of DCM [88]. This evidence concerns the gene MAPK3 and familial dilated cardiomyopathy.